Saratov JOURNAL of Medical and Scientific Research

Cognitive disorders in patients with chronic kidney disease in the pre-dialysis period

Year: 2021, volume 17 Issue: №1 Pages: 136-142
Heading: Тhematic supplement Article type: Original article
Authors: Nikitina A.A., Khrulev A.E., Kuznetsov A.N.
Organization: Privolzhskiy Research Medical University

Objective: to study the cognitive status of patients in the pre-dialysis period depending on the stage of chronic kidney disease (CKD) and the category of cardiovascular risk (CVR). Material and Methods. We examined 98 patients with CKD in the pre-dialysis period (mean age 47.1 ±11.2 years). The patients were divided into 3 groups according to the criteria of CVR stratification. Group 1 consisted of 32 patients with low and moderate CVR and CKD stage C1 or C2; group 2 included 34 patients with high CVR and CKD stage C3a or C3b; group 3 assumed 32 patients with very high CVR and CKD stage C4. The SAGE test (Self-administered Gerocognitive Examination) was used to assess cognitive functions. Results. Cognitive impairment (Cl) was detected in 57% of the patients: in the 1st group in 37.5%; in the 2nd group in 44.1 %; in 3rd group in 90.5%. Dementia was diagnosed in 19% of patients with Cl. A correlation was found between the severity of Cl, the degree of decrease in glomerular filtration rate, and the educational qualification of patients with CKD in the pre-dialysis period (p<0.001). It was found that the examined persons CKD first of all had memory, constructive-spatial and logical thinking disorders. Conclusion. Chronic kidney disease is an independent risk factor for the development of Cl. Cognitive impairment progressed as the CKD stage elevated and the patient's CVR category increased, and was detected in 37.5% of patients with low or moderate CVR, 44.1% of patients with high CVR, and 90.5% of patients with very high CVR.

1. Kam-Tao Li P, Garcia-Garcia G, Lui S-F, et al. Kidney health for everyone everywhere: from prevention to detection and equitableaccessto care. Therapeutic Archive 2020; 92 (6): 4-14.
2. Hill NR, Fatoba ST, Оке JL, et al. Global prevalence of chronic kidney disease: A systematic review and meta-analysis. PLoS One 2016; 11 (7): e0158765.
3. Chronic kidney disease: Clinical guidelines/Association of Nephrologists of Russia, 2019. Russian (Хроническая болезнь почек: клинические рекомендации/Ассоциация нефрологов России, 2019. URL: /Clin_guidlines_CKD_24.11_final-3-3. pdf (12 марта 2020)).
4. Mach F, Baigent С, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal 2020; 41 (1): 111-88.
5. Nikitina AA, Khrulev AE. Cerebrovascular disorders of the predialysis period of chronic kidney disease and development mechanisms. Medical Almanac 2018; 56 (5): 28-32.
6. Khrulev AE, Nikitina AA, Khruleva NS. Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period. Cardiovascular Therapy and Prevention 2019; 18 (3): 88-93.
7. Polyakova IV, Borovkova NYu, Maslova Tl, et al. View of the vascular stiffness and cardiovascular risk in patients with chronic glomerulonephritis. Therapy 2019; 28 (2): 89-94.
8. Rogova IV, Fomin VV, Damulin IV, et al. Vascular cognitive impairments in chronic kidney disease. Neurology, Neuropsychiatry, Psychosomatics 2015; 7 (1): 11-8.
9. Mark РВ. Strategies to manage cardiovascular risk in chronic kidney disease. Nephrology Dialysis Transplantation 2017; 33(1): 23-5.
10. KhrulevAE, Studyanikova SF, Langraf SV, etal. Cognitive impairment in patients on hemodialysis. Neurology Bulletin 2019; 51 (2): 36-40.
11. Khrulev АЕ, Tolbuzova DD, Plokhenko ЕА, et al. Cognitive status and risk factors for cognitive impairment in dialysis patients. General Reanimatology 2020; 16 (4): 21-31.
12. Etgen Т, Chonchol М, Forstl Н, Sander D. Chronic kidney disease and cognitive impairment: A systematic review and meta-analysis. Am J Nephrol 2012; 35 (5): 474-82.
13. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate. JAMA 2012; 307 (18): 1941-51.
14. Scharre DW, Chang S-l, Murden RA, et al. A Brief Cognitive Assessment Instrument for Mild Cognitive Impairment (MCI) and Early Dementia. Alzheimer Dis Assoc Disord 2010; (24): 64-71.
15. Berger I, Wu S, Masson P, et al. Cognition in chronic kidney disease: A systematic review and meta-analysis. ВМС Med2016; 14(206).

2021_01-1_136-142.pdf484.58 KB

No votes yet